Association of insulin promoter factor-1 gene mutation with the pathogenesis of diabetes in Shanghai

Yu-fan Wang,Jian-bo Wang,Jie Liu,Yu-fei Wang,Zheng-yan Sheng,Long Yu,Yong-de Peng
DOI: https://doi.org/10.3321/j.issn:1673-8225.2005.39.007
2005-01-01
Abstract:Aim: To screen the insulin promoter factor-1 (IPF-1) gene sequence in type 2 diabetics, idiopathic type 1 diabetics and control subjects in Shanghai, so as to investigate the role of IPF-1 gene in the pathogenesis of diabetes. Methods: 1 Between May 2002 and December 2003 , 201 type 2 diabetics (94 males and 107 females, type 2 diabetic group) and 4 idiopathic type 1 diabetics (3 males and 1 female, idiopathic type 1 diabetic group), who were hospitalized in the Department of Endocrinology, the First People's Hospital affiliated to Shanghai Jiaotong University, and 100 healthy physical examinees (control group) all participated in the study voluntarily. 2 The biochemical indexes and antibody related to the pathogenesis of diabetes mellitus were detected. Two exons of IPF-1 (including the coding and flanking regions) were amplified with polymerase chain reaction (PCR). After being purified, the PCR products were directly sequenced with ABI 377 automatic DNA sequencer. The mutation was confirmed by digestion of the PCR products with restriction enzyme. 3 The data of normal distribution were expressed as mean±SD, the data of partial distribution were expressed as M, C peptide showed partial distribution, but normal distribution after being changed to the logarithm taking 10 as base. Results: All the 201 type 2 diabetics, 4 i diopathic type 1 diabetics and 100 healthy subjects entered the analysis of results. No IPF-1 gene mutation was found in either the type 2 diabetic group or control group, and A P239Q (CCG-CAG) heterozygous mutation was detected in one case of the idiopathic type 1 diabetic group. The PCR product was partially digested into fragments of 347 bp and 252 bp by restriction enzyme Pst I. Conclusion: 1 The results suggest that IPF-1 gene does not play an i mportant role in the development of type 2 diabetes in Shanghai. 2 A P239Q (CCG-CAG) heterozygous mutation was found in one of the idiopathic type 1 diabetics. More samples and further pedigree investigation will be required to make clear the relationship between IPF-1 gene mutation and islet dysfunction during the early stage of idiopathic type 1 diabetes. It may provide a new clue for the pathogenesis study of idiopathic type 1 diabetes.
What problem does this paper attempt to address?